AstraZeneca Pharma India Ltd Q3 FY2022-23 PAT at Rs. 29.30 crores

AstraZeneca Pharma India Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 257.0046 crores during the period ended December 31, 2022 as compared to Rs. 242.9211 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 29.3044 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 32.5643 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 11.72 for the period ended December 31, 2022 as compared to Rs. 13.03 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹257.0046 crs	₹242.9211 crs	5.80%
Net Profit	₹29.3044 crs	₹32.5643 crs	-10.01%
EPS	₹11.72	₹13.03	-10.05%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.257.0046 crores during the period ended December 31, 2022 as compared to Rs.205.8678 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.29.3044 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.11.4192 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.11.72 for the period ended December 31, 2022 as compared to Rs.4.57 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹257.0046 crs	₹205.8678 crs	24.84%
Net Profit	₹29.3044 crs	₹11.4192 crs	156.62%
EPS	₹11.72	₹4.57	156.46%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.738.3719 crores during the 9 Months period ended December 31, 2022 as compared to Rs.584.7105 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.82.0213 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.33.8096 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.32.81 for the 9 Months period ended December 31, 2022 as compared to Rs.13.44 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹738.3719 crs	₹584.7105 crs	26.28%
Net Profit	₹82.0213 crs	₹33.8096 crs	142.60%
EPS	₹32.81	₹13.44	144.12%

Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 3377.00 as compared to the previous close of Rs. 3372.90. The total number of shares traded during the day was 195 in over 126 trades.

The stock hit an intraday high of Rs. 3405.00 and intraday low of 3358.10. The net turnover during the day was Rs. 658882.00.

Source : Equity Bulls

Keywords

AstraZenecaPharmaIndia Q3FY23 9MFY23 ResultUpdate